Everyday Freedom™For Your Plan Members

A breakthrough treatment for anxiety attacks and PTSD symptoms

Freespira is the only FDA-cleared treatment proven to reduce or eliminate panic attacks and post-traumatic stress disorder (PTSD) symptoms. Unlike medication or talk therapy, in 28 days Freespira addresses the underlying breathing irregularities for individuals suffering from these debilitating anxiety conditions.

Living with anxiety attacks or traumatic stress symptoms can be scary.

Typical symptoms may include:




Freespira is helping to break down access barriers as an at-home treatment option for panic disorder and PTSD that does not require a doctor or therapist visit.

Freespira is a great alternative for our members.
— Mark RakowskiChief Operating Officer
Children’s Community Health Plan
This breakthrough drug-free treatment approach has reduced the impact of symptoms associated with panic disorder and PTSD, resulting in reduced use of medications and other healthcare costs for symptom management.
— Demetrios C. Marousis, MA, MBA, LPCDirector, Behavioral Health
Highmark, Inc.

Help your members overcome panic attacks and PTSD symptoms.

Learn more

Practical, proven treatment for anxiety attacks

Panic attacks and PTSD impact plan spend. These conditions lead to significantly higher average additional claims spend per patient:

Combined, comorbid prevalence of panic disorder and PTSD adults and teens3

Panic attacks accompany a range of other health conditions. The 28.3% lifetime prevalence of panic attacks means many people experience a panic attack without meeting the full diagnostic criteria for panic disorder.4


Panic disorder patients have at least one behavioral health comorbidity; among the most common, major depressive disorder, anxiety disorder, and alcohol use disorders5

Freespira is an accessible at-home treatment that doesn’t require a doctor or therapist visit.
Freespira is the only FDA-cleared, medication-free digital therapeutic proven to reduce or eliminate panic attacks and PTSD symptoms.
Freespira is easy to use, with treatment adherence averaging >70%.
I now notice when my chest tightens from anxiety and then I focus on my breath and the symptoms go away. I feel like I have learned to take control of my anxiety and I will use this awareness for the rest of my life.

— Freespira Patient

Freespira Reduced Total Cost of Care by 35%6


Patients experienced symptom reduction:

Patients saw significant reduction in symptoms of panic disorder and PTSD post-treatment6, 7
Panic disorder patients had significantly fewer symptoms 1-year post-treatment8
Patients were still panic attack-free one-year post-treatment8
PTSD patients had clinically significant reductions in symptoms 6 months later7
PTSD patients were in remission 6 months later7

Health plan saw reduction in medical costs6:

Reduction in emergency department costs
Reduction in pharmacy costs
Reduction in total medical costs

Visit our resources to read study overviews.

Visit Now

Get Started With Accessible Behavioral Health Support

Freespira is a new, FDA-cleared breathing treatment accessible for all. Getting started doesn’t require a doctor or therapist’s appointment—just a brief clinical assessment to determine suitability.

Typical implementation in 6+ weeks is guided by an onboarding manager and includes clinical team and case manager referral/training, and targeted multi-channel communications to expand membership awareness and engagement.


Freespira is a medication-free, twice daily treatment that normalizes breathing behavior which eliminates or reduces panic and PTSD symptoms. Each Freespira patient receives a sensor and tablet and is assigned a dedicated coach to virtually guide them through treatment sessions. After 28 days, more than 80% of patients saw a significant reduction in symptoms of panic disorder and PTSD6, 7.

Learn more about how we work with health plans.


*Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older. In younger patients, Freespira has been evaluated and is being made available as permitted by FDA’s COVID-19 Enforcement Discretion Guidance.

1 See Konnopka, et al., https://pubmed.ncbi.nlm.nih.gov/31646432/
2 See National Academies, https://pubmed.ncbi.nlm.nih.gov/25077185/
3 See National Institutes of Health, https://www.nimh.nih.gov/health/statistics/panic-disorder
4 See Kessler, et al., https://pubmed.ncbi.nlm.nih.gov/16585471/
5 See Virpi, et al., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520420/
6 See Kaplan, et al., https://doi.org/10.1007/s10484-020-09465-0
7 See Ostacher, et al., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553693/
8 See Tolin, et al., https://pubmed.ncbi.nlm.nih.gov/28194546/